Baird Medical Expands U.S. Footprint in Interventional Thyroidology
Event summary
- Baird Medical showcased its Microwave Ablation (MWA) technology at NASIT 2026 in Portland, Oregon, on March 9, 2026.
- The company engaged with Key Opinion Leaders (KOLs) and emerging physicians to discuss clinical applications of MWA.
- Baird Medical's technology is already used in over 30 prestigious hospitals and clinics across the United States.
- The company is the market leader in China for thyroid microwave ablation devices and consumables.
The big picture
Baird Medical's strategic showcase at NASIT 2026 underscores its push to expand patient access to minimally invasive thyroid treatments in the U.S. The company's established presence in over 30 hospitals, including Mayo Clinic and Columbia University Medical Center, positions it well to capitalize on growing demand for non-surgical interventions. Its leadership in China's thyroid ablation market further highlights its potential to leverage cross-border expertise in precision therapies.
What we're watching
- Adoption Pace
- How quickly Baird Medical can scale its MWA technology adoption in the U.S. following NASIT 2026.
- Regulatory Dynamics
- Whether Baird Medical can navigate regulatory conditions to expand its business in the U.S. and China.
- Competitive Positioning
- The pace at which Baird Medical can maintain its market leadership in China while expanding in the U.S.
Related topics